Gainers •$Anaplan (PLAN.US)$+28.2% (to be acquired by Thoma Bravo for $66.00 per share) •$Guess (GES.US)$+5.04% (entered into an accelerated share repurchase agreement to repurchase $175 mln of its common stock) •$Membership Collective (MCG.US)$+2.8% (authorizes stock repurchase program to repurchase up to $50 mln of the Company's Class A common stock) •$Sorrento Therapeutics (SRNE.US)$+2.3% (reports promising results with a universal...
AvePoint股票讨论
• $Anaplan (PLAN.US)$ +28.2% (to be acquired by Thoma Bravo for $66.00 per share)
• $Guess (GES.US)$ +5.04% (entered into an accelerated share repurchase agreement to repurchase $175 mln of its common stock)
• $Membership Collective (MCG.US)$ +2.8% (authorizes stock repurchase program to repurchase up to $50 mln of the Company's Class A common stock)
• $Sorrento Therapeutics (SRNE.US)$ +2.3% (reports promising results with a universal...
• $Air Products & Chemicals (APD.US)$摩根大通从中立升级至增持-目标价 $275
• $Associated Banc (ASB.US)$富国银行从等权重升级至增持-目标价 $28（由 $26）
• $阿姆斯特朗工业 (AWI.US)$Jefferies将评级从持有调升至买入-目标价111美元（由101美元）
• $黑莓 (BB.US)$RBC Capital将评级从表现不佳调升至板块表现-目标价7美元
• $科默斯银行 (CBSH.US)$富国银行从...升级至等权重
据我们所知，新变种似乎更具抗药性。这意味着我们需要新的疫苗来应对这个新的变种。
我们如何将这一假设转化为股票头寸？
我对制药行业不太熟悉，不知道制药行业的运作方式。但根据我所知，通常会有一些小型初创公司进行创新，开发疫苗技术，然后大型企业会收购它们。
那么，在新冠疫情变得定价市场时，我们应该如何预期生物科技股的表现？
要等很长时间才能触及11美元💩
暂无评论